Medical infographic mapping the sites of action for anti-tau therapeutic agents in development for Alzheimer’s disease. The visual tracks the tau pathway from MAPT gene expression through tau aggregation, phosphorylation, and accumulation—highlighting where small molecules, immunotherapies, and experimental compounds intervene to disrupt pathology and slow neurodegeneration. Created for Cummings, J., Lee, G., Ritter, A., & Zhong, K. (2018) in Alzheimer’s Disease Drug Development Pipeline: 2018 (Alzheimer’s & Dementia, 4, 195–214).
© Mike de la Flor. All Rights Reserved.